Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trials

This work was supported by the Coalition for Epidemic Preparedness Innovations (CEPI), The National Institute of Allergy and Infectious Diseases (NIAID)/National Institutes of Health (NIH), The Bill and Melinda Gates Global Vaccine Accelerator Program, the Burroughs Wellcome Fund, and financial gifts and support by Nancy Zimmerman, Mark and Lisa Schwartz, and Terry and Susan Ragon.

Authors

Institutions

Publication Details

Journal
EBioMedicine
Published
2025-04-01
DOI
https://doi.org/10.1016/j.ebiom.2025.105647
Citations
9
Primary Topic
Viral Infections and Outbreaks Research
Type
article
Field-Weighted Citation Impact
12.57
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trials

John D. Aitchison, Christopher L. Cooper, Joanne DeStefano, Alexei Carpov et al.
9 citations
EBioMedicine
Viral Infections and Outbreaks Research
12.57
article

Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trials

John D. Aitchison, Christopher L. Cooper, Joanne DeStefano, Alexei Carpov, Shui L. Li, Fuxiang Hou, Krystle N. Agans, Andy Kilianski, Adrian Enriquez, Courtney Woolsey, Maxwell Lewis Neal, Olivia Wallace-Selman, John W. Coleman, Robert W. Cross, Suzane Ramos da Silva, Anne M. Ercolini, Yesle Choi, Viktoriya Borisevich, Thomas W. Geisbert, Mark B. Feinberg, Vicky Roy, Erica Ollmann Saphire, Denise Wagner, Gavin Morrow, Lucia Reiserova, Aaron Wilson, Thomas S. Postler, Ryan P. McNamara, Galit Alter, Fuqiang Geng, Eddy Sayeed, Maoli Yuan, Kathryn M. Hastie, Deborah Frederick, Daritza Germosen, Swati B. Gupta, Caroline Atyeo, Christopher L. Parks
article en
9 citations

Abstract

This work was supported by the Coalition for Epidemic Preparedness Innovations (CEPI), The National Institute of Allergy and Infectious Diseases (NIAID)/National Institutes of Health (NIH), The Bill and Melinda Gates Global Vaccine Accelerator Program, the Burroughs Wellcome Fund, and financial gifts and support by Nancy Zimmerman, Mark and Lisa Schwartz, and Terry and Susan Ragon.

EBioMedicineVol. 114
Center for Infectious Disease Research (US), International AIDS Vaccine Initiative (US), La Jolla Institute for Immunology (US), Infectious Disease Research Institute (US), University of Washington (US), Ragon Institute of MGH, MIT and Harvard (US), The University of Texas Medical Branch at Galveston (US)
Good health and well-being
Openalex Percentile: Top 1%
Viral Infections and Outbreaks Research
12.57
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.